Latest Form 4 insider transactions

NASDAQ
Charles Liang, President and CEO, a Director and 10% owner of Super Micro Computer, Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
Kevin Francis Egan, a Director of Icon Plc, received 1,324 shares of common stock on August 10, 2026.
NYSE
Francoise Colpron, a Director of Celestica Inc, received 203 shares of common stock on August 11, 2026.
NYSE
Robert Cascella, a Director of Celestica Inc, received 142 shares of common stock on August 11, 2026.
NYSE
Kulvinder Ahuja, a Director of Celestica Inc, received 133 shares of common stock on August 11, 2026.
NASDAQ
Steven Pieper, See Remarks of Xeris Biopharma Holdings, Inc., sold 5,000 shares of common stock on August 12, 2026 for $8.50 per share.
NASDAQ
Kevin J Mills, a Director of Socket Mobile, Inc., sold 1,946 shares of common stock on August 10, 2026 for $1.80 per share.
NYSE
John T Reilly, President & CEO and a Director of Six Flags Entertainment Corporation/NEW, purchased 15,713 shares of common stock on August 12, 2026 for $15.80 per share.
NYSE
Argon Holdco LLC and 5 others reported changes in beneficial ownership of Blackstone Inc. common stock on August 10, 2026.
NYSE
Argon Holdco LLC and 5 others reported changes in beneficial ownership of Corebridge Financial, Inc. common stock on August 10, 2026.
NYSE
Brenna C Garrett, SVP, CCO of Sysco Corp, reported a transaction in 87 shares of common stock on August 10, 2026.
NYSE
Stephen Dale Higgs, SVP of Sysco Corp, reported a transaction in 310 shares of common stock on August 10, 2026.
NASDAQ
David E Weigand, SVP, Chief Financial Officer of Super Micro Computer, Inc., reported multiple transactions in common stock on August 10, 2026.
NYSE
Kevin Hourican, Chair and CEO and a Director of Sysco Corp, reported a transaction in 6,309 shares of common stock on August 10, 2026.
NYSE
Gregory Scott Keller, EVP of Sysco Corp, reported a transaction in 495 shares of common stock on August 10, 2026.
NYSE
Brandon Elliot Sewell, Interim CFO of Sysco Corp, reported a transaction in 79 shares of common stock on August 10, 2026.
NYSE
Ronald L Phillips, EVP and CHRO of Sysco Corp, sold 6,652 shares of common stock on August 10, 2026.
NASDAQ
Gautam Patel, a Director of Amneal Pharmaceuticals, Inc., received 283,632 shares of common stock on August 10, 2026.
NYSE
Richard Mccathron, Chief Executive Officer and a Director of Hippo Holdings Inc., sold 5,000 shares of common stock on August 10, 2026 for $32.00 per share.
NASDAQ
Darren S Raiguel, CHIEF OPERATING OFFICER of Eplus Inc, sold 1,000 shares of common stock on August 10, 2026.
Michael Reed, Chief Executive Officer and a Director of Gannett Co., Inc., received 383,771 shares of common stock on August 11, 2026.
NASDAQ
Chirag K. Patel, President & Co-CEO and a Director of Amneal Pharmaceuticals, Inc., received 6,381,734 shares of common stock on August 10, 2026.
NASDAQ
Michael P. Monahan, Chief Financial Officer of Beauty Health Co, reported a transaction in 32,357 shares of common stock on August 10, 2026.
James M. Kapenstein, SEE REMARKS of Lions Gate Entertainment Corp /Cn/, purchased 1,000 shares of common stock on August 10, 2026 for $25.73 per share.
NASDAQ
Abraham Ceesay, Chief Executive Officer and a Director of Rapport Therapeutics, Inc., sold 51,499 shares of common stock on August 10, 2026.
NYSE
Ann Aber, Chief Legal Officer &Corp Secy of Bath & Body Works, Inc., received 12,940 shares of common stock on August 10, 2026.
NASDAQ
Jacqueline C Mutschler, a Director of Weatherford International plc, sold 4,094 shares of common stock on August 10, 2026 for $90.50 per share.
NASDAQ
Scott A. Green, President and COO of Orion Energy Systems, Inc., reported multiple transactions in common stock on August 11, 2026.
NYSE
Mohsen Sohi, a Director of STERIS plc, sold 4,058 shares of common stock on August 10, 2026 for $235.78 per share.
NASDAQ
Cyclerion Therapeutics announces progress on its merger with Korsana Biosciences, highlighting potential advancements in neurodegenerative disease therapies.